Cardiovascular Protection Reduces Cardiovascular Events Semaglutide has been shown to reduce the risk of major cardiovascular events, such as heart attacks and strokes
If nutritional care is not integrated alongside treatment, theres a risk of replacing one set of health problems with another, through preventable nutritional deficiencies and largely avoidable loss of muscle mass
First, the two medicines in Contrave target the pathways known to regulate mood, energy expenditure, cravings, and pleasure sensation in the brain, said Allison Rhodes, MD, dual-certified obesity medicine and internal medicine physician at The Ohio State University Wexner Medical Center
GLP-1 drugs for heart protection in autoimmune disease may offer benefits beyond weight loss and blood sugar control
By the time the SNAC patents expire, Novo expects to have successfully transitioned its patient base to high-dose oral Wegovy or next-generation co-agonists, effectively evergreening the franchise
Some patients experience depression when facing vision problems
